FIELD: chemical-pharmaceutical industry, pharmacy. SUBSTANCE: invention relates to a medicinal form of tinidazole representing a core covered by envelope and comprising tinidazole as an active component and starch, sorbitol or microcrystalline cellulose, pregelatinized starch, or lactose, talc and stearic acid as special additions. EFFECT: enhanced bioavailability of form described. 5 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY AND METHOD FOR ITS PREPARING | 2003 |
|
RU2222333C1 |
| PHARMACEUTICAL ANTIULCEROUS COMPOSITION AND METHOD OF ITS PREPARING | 2001 |
|
RU2179022C1 |
| PROLONGED ACTION PREPARATION OF DICLOFENAC SODIUM | 2002 |
|
RU2221559C1 |
| METHOD FOR PRODUCING COMPOSITION AND COMPOSITION SHOWING ANTIBACTERIAL ACTIVITY | 2001 |
|
RU2182825C1 |
| PHARMACEUTICAL COMPOSITION WITH ANTIDIABETIC EFFECT AND METHOD OF ITS PREPARING | 2000 |
|
RU2177318C1 |
| PHARMACEUTICAL COMPOSITION ELICITING WITH ANTIBACTERIAL EFFECT AND METHOD FOR IT PREPARING | 2002 |
|
RU2230557C1 |
| ANTITUBERCULAR PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2248797C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| PHARMACEUTICAL COMPOSITION FOR ALLERGIC DISORDER TREATMENT | 2005 |
|
RU2283649C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING CARDIOSELECTIVE BETA-ADRENOBLOCKER | 2001 |
|
RU2190397C1 |
